Skip to main content

Year: 2022

Palisade Bio Announces Executive Leadership Transition

Board Appoints JD Finley to Interim Chief Executive Officer Carlsbad, CA, Oct. 11, 2022 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, today announced an executive leadership transition. Effective October 10, 2022, Thomas Hallam, Ph.D., ceased his duties as chief executive officer (CEO). The company’s board of directors has appointed JD Finley, current chief financial officer (CFO), as interim CEO, and Mr. Finley has assumed the duties of Dr. Hallam effective October 10, 2022. “On behalf of my fellow directors, I would like to thank Tom for his dedication to Palisade Bio over the last nine years,” said James R. Neal, chairman of the board of Palisade Bio. “Tom was instrumental in the development LB1148....

Continue reading

Philips Ambient Experience solution at Children’s Medical Center Dallas helps calm young patients with behavioral health issues, winning multiple design awards

Philips behavioral health experience solution 1Philips behavioral health experience solution 2Philips behavioral health experience solution 3Philips behavioral health experience solution 4October 11, 2022Philips receives Center for Health Design ‘Touchstone Award’ for exemplary use of evidence-based design in Ambient Experience solutions that help the emergency department at Children’s Medical Center Dallas improve care for pediatric patients with behavioral health issues Behavioral health solution recognized by three other awards and an honorable mention in the last year as an outstanding example of Philips’ ability to improve the patient and staff experience in the pursuit of better healthcare deliveryAmsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today...

Continue reading

Innovative Payment Solutions Announces Availability of MeMD Telemedicine Offering through its IPSIPay® App

IPSI continues its efforts to build its IPSIPay® super app providing financial and other services to support unbanked and underserved communities CARMEL BY THE SEA, Calif., Oct. 11, 2022 (GLOBE NEWSWIRE) — Innovative Payment Solutions, Inc. (OTCQB:IPSI) (“IPSI” or the “Company”), a fintech provider of digital payment and other solutions to both business owners and consumers, today announces the availability of MeMD (also known as Walmart Health Virtual Care), providing a comprehensive telemedicine offering via the Company’s IPSIPay® app.   Founded in 2010 and acquired by Walmart in 2021, MeMD is a leading provider of around-the-clock telemedicine and mental health care services with five million users nationwide. IPSIPay® mobile app users will now have access to highly qualified, licensed healthcare providers using MeMD to address...

Continue reading

Athenex Files Definitive Proxy Statement for Special Stockholder Meeting

Special Stockholder Meeting will be held as a virtual meeting on November 22, 2022 at 9:30 a.m. Eastern TimeBUFFALO, N.Y., Oct. 11, 2022 (GLOBE NEWSWIRE) — Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that it has filed a definitive proxy statement with the Securities and Exchange Commission in connection with a special meeting of stockholders (the “Special Meeting”) scheduled on November 22, 2022 (to be held virtually as a live webcast). The Special Meeting is being held to vote on three matters, including to effect an increase in the total number of authorized shares of common stock of the Company, to effect a reverse stock split of the issued...

Continue reading

Blue Water Vaccines Announces Plans to Evaluate Efficacy of Streptococcus pneumoniae Vaccine Candidate Against Pneumococcal Pneumonia at the World Vaccine Congress in Barcelona

CINCINNATI, Oct. 11, 2022 (GLOBE NEWSWIRE) — Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced plans to investigate the ability of BWV-201, a Streptococcus pneumoniae vaccine candidate for acute otitis media (“AOM”) prevention, to also protect against non-invasive pneumococcal pneumonia at the World Vaccine Congress in Barcelona. While Streptococcus pneumoniae is commonly found in the nose and throat of healthy individuals, overgrowth and spread of the bacteria can result in pneumococcal disease. Non-invasive forms of pneumococcal disease include AOM, sinusitis, and pneumococcal pneumonia, while invasive forms include bacteremia, sepsis, and pneumococcal meningitis. BWV’s new...

Continue reading

Blink Charging Announces the All-New Blink Network and Blink Charging Mobile App, Redesigned from the Ground Up, Powering the Next-Generation EV Charging Experience

Blink updates its driver and host platforms with industry-leading architecture, improving reliability, user experience, and flexibility capable of iterating as the industry matures The completely rebuilt Blink Network will serve as a foundation for a global charging platform unlike anything currently available, capable of serving a wide variety of EV equipment, languages, currencies, and applications Best-in-class new mobile app creates a seamless driver charging experience across the globeMiami, FL, Oct. 11, 2022 (GLOBE NEWSWIRE) — Blink Charging Co. (Nasdaq: BLNK, BLNKW) (“Blink”), a leading owner and operator of electric vehicle (EV) charging equipment and services, today announced the launch of its entirely rebuilt Blink Network with market-leading architecture and responsiveness capable of meeting the needs of the Company...

Continue reading

BOK Financial Corporation announces third quarter 2022 earnings conference call

TULSA, Okla., Oct. 11, 2022 (GLOBE NEWSWIRE) — BOK Financial Corporation (NASDAQ: BOKF) will announce financial results for the third quarter of 2022 which will be released before market open on Wednesday, Oct. 26, 2022. The company will hold a conference call at 9 a.m. central time that morning to discuss the financial results with investors. The live audio webcast and presentation slides will be available on the company’s investor relations website. The conference call can also be accessed by dialing 1.877.407.4018 toll free, or 1.201.689.8471, conference ID: 13733709. A webcast replay will be available shortly after the live call’s conclusion on the company’s investor relations website or by dialing 1.844.512.2921 and referencing replay PIN 13733709. About BOK Financial CorporationBOK Financial Corporation is a $45...

Continue reading

Mondelēz International Celebrates 130th Anniversary of Historic Toledo Flour Mill; Milestone Honored with Recognition from Ohio Congressional and State Officials

Celebration recognizes Mill employees who supply flour for consumer-favorite snacksMondelēz International Toledo Mill Celebration Mondelēz International marked the 130th anniversary of its Biscuit Flour Mill in Toledo, Ohio with a ceremony on Saturday, October 8, 2022, that highlighted the important role the Mill plays as a part of Mondelēz International’s U.S. snacking supply chain. Pictured from right to left, Dee Lewis, Plant Lead at Mondelēz International’s Toledo Flour Mill, and Claudio Parrotta, SVP & Chief Supply Chain Officer, North America at Mondelēz International, accepted official proclamations on behalf of the company and welcomed Ohio dignitaries, including Ohio State Senator Teresa Fedor, Congresswoman Marcy Kaptur and Toledo Mayor Wade Kapszukiewicz.MDLZ Toledo Flour Mill Mondelēz International’s Toledo Flour...

Continue reading

First Eagle Alternative Capital BDC, Inc. Schedules Earnings Release and Conference Call for the Third Quarter Ended September 30, 2022

BOSTON, Oct. 11, 2022 (GLOBE NEWSWIRE) — First Eagle Alternative Capital BDC, Inc. (NASDAQ: FCRD) (the “Company”) today announced that it will report its financial results for the third fiscal quarter ended September 30, 2022, after the market closes on Tuesday, November 8, 2022. The Company will host a conference call to discuss these results and its business outlook on Wednesday, November 9, 2022, at 9:30 a.m. Eastern Time. For those wishing to participate by telephone, please register here. The Company will also broadcast the conference call live via the Investor Relations section of its website at www.feacbdc.com. Starting approximately two hours after the conclusion of the call, a replay will be available through Thursday, November 9, 2023, by clicking here. The replay will also be available on the Company’s website. About...

Continue reading

Denny’s Corporation Announces Timing of Third Quarter 2022 Results and Conference Call on November 1, 2022

SPARTANBURG, S.C., Oct. 11, 2022 (GLOBE NEWSWIRE) — Denny’s Corporation (NASDAQ: DENN), franchisor and operator of one of America’s largest franchised full-service restaurant chains, will announce financial and operating results for its third quarter ended September 28, 2022, on Tuesday, November 1, 2022, after the markets close. Senior management will hold a conference call on the same day at 4:30 p.m. Eastern Time to discuss these results and answer questions. Interested parties are invited to listen to a live broadcast of the conference call accessible through the Investor Relations section of the Denny’s website at investor.dennys.com. For any questions, please contact Denny’s Investor Relations Department at 877-784-7167. About Denny’s Denny’s Corporation is the franchisor and operator of one of America’s...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.